T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$2.39B |
| 2 |
Carvana
CVNA
|
+$1.82B |
| 3 |
Microsoft
MSFT
|
+$1.5B |
| 4 |
Walt Disney
DIS
|
+$1.25B |
| 5 |
Spotify
SPOT
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.65B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.87B |
| 4 |
Salesforce
CRM
|
+$1.76B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Healthcare | 16.26% |
| 3 | Consumer Discretionary | 15.34% |
| 4 | Communication Services | 13.82% |
| 5 | Financials | 12.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Veracyte
VCYT
$3.42B
| $1.48M | ﹤0.01% |
31,865
+1,261
| +4% | +$55K |
|
|
WGSWW
1852
DELISTED
GeneDx Holdings Warrant
WGSWW
| $1.48M | ﹤0.01% |
+696,994
| New | +$2.29M |
|
1853
La-Z-Boy
LZB
$1.64B
| $1.48M | ﹤0.01% |
45,823
+116
| +0.3% | +$4K |
|
1854
Rogers Corp
ROG
$2.48B
| $1.48M | ﹤0.01% |
7,917
-393
| -5% | -$77.3K |
|
|
MNR
1855
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $1.47M | ﹤0.01% |
79,011
+12,400
| +19% | +$235K |
|
1856
Liberty Global Class A
LBTYA
$3.55B
| $1.47M | ﹤0.01% |
49,429
-2,400
| -5% | -$66.5K |
|
1857
MSC Industrial Direct
MSM
$6.67B
| $1.47M | ﹤0.01% |
18,366
+407
| +2% | +$34.6K |
|
1858
Moelis & Co
MC
$4.91B
| $1.46M | ﹤0.01% |
23,539
-1,012
| -4% | -$60.6K |
|
1859
FuboTV Inc
FUBO
$296M
| $1.45M | ﹤0.01% |
5,046
+1,318
| +35% | +$431K |
|
1860
Plexus
PLXS
$7.25B
| $1.44M | ﹤0.01% |
16,110
-702
| -4% | -$62.4K |
|
|
TRTN
1861
DELISTED
Triton International Limited
TRTN
| $1.44M | ﹤0.01% |
27,606
-3,163
| -10% | -$164K |
|
|
DEN
1862
DELISTED
Denbury Inc.
DEN
| $1.44M | ﹤0.01% |
20,438
+4,665
| +30% | +$322K |
|
1863
Stock Yards Bancorp
SYBT
$2.64B
| $1.43M | ﹤0.01% |
24,386
-15,960
| -40% | -$817K |
|
|
AZEK
1864
DELISTED
The AZEK Co
AZEK
| $1.43M | ﹤0.01% |
39,098
-437
| -1% | -$17K |
|
1865
iShares S&P Small-Cap 600 Value ETF
IJS
$8.43B
| $1.43M | ﹤0.01% |
14,156
| – | – |
|
1866
Macerich
MAC
$6.99B
| $1.42M | ﹤0.01% |
84,803
+1,226
| +1% | +$20.8K |
|
1867
Ashland
ASH
$3.36B
| $1.41M | ﹤0.01% |
15,836
-970
| -6% | -$85.1K |
|
1868
CALL
AstraZeneca
AZN
$244B
| $1.41M | ﹤0.01% |
11,750
+1,150
| +11% | +$134K |
|
|
SAVE
1869
DELISTED
Spirit Airlines, Inc.
SAVE
| $1.41M | ﹤0.01% |
54,326
-243
| -0.4% | -$6.37K |
|
|
UMPQ
1870
DELISTED
Umpqua Holdings Corp
UMPQ
| $1.41M | ﹤0.01% |
69,594
-16,540
| -19% | -$317K |
|
1871
Universal Corp
UVV
$1.13B
| $1.41M | ﹤0.01% |
29,118
+7,600
| +35% | +$386K |
|
1872
Crinetics Pharmaceuticals
CRNX
$8.96B
| $1.39M | ﹤0.01% |
66,163
+238
| +0.4% | +$4.98K |
|
|
CADE
1873
DELISTED
Cadence Bank
CADE
| $1.39M | ﹤0.01% |
46,727
-6,551
| -12% | -$183K |
|
1874
FuelCell Energy
FCEL
$1.63B
| $1.39M | ﹤0.01% |
6,910
+217
| +3% | +$43.1K |
|
|
LTHM
1875
DELISTED
Livent Corporation
LTHM
| $1.39M | ﹤0.01% |
60,017
+1,145
| +2% | +$25.7K |
|
Similar funds
T. Rowe Price Associates's Q3 2021 Portfolio in Review
As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
- T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
- T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
- T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
- T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
- T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.
Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.